niuz

UAE becomes third country globally to approve Foundayo for type 2 diabetes

1 source
One source
What the source said
Gulf News
“UAE becomes third country globally to approve Foundayo for type 2 diabetes”

Abu Dhabi: The Emirates Drug Establishment (EDE) has approved a new therapeutic use for Foundayo (orforglipron), an oral medication developed by US pharmaceutical company Eli Lilly, to treat type 2 diabetes in adults, making the UAE the third country in the world to authorise the medicine for this purpose, according to the regulator. The approval expands the use of the drug, which was previously authorised by the EDE for chronic weight management in April 2026, when the UAE became the second…

Read at Gulf News
Is this point wrong? Tell us

Reported by one source so far. It is confirmed when a second, independent source reports the same thing.

Top world stories now

How recent

The shading behind a date drains as it ages: full when new, three quarters at 1 hour, half at 6 hours, a quarter at 12 hours, empty after a day. The date is when the source published it.

Timeline

The line under a story shows when it was reported. Now is at the end. The shaded part runs from its first article to its latest; each mark is an article, taller where several came out within 15 minutes. In lists the line is the last two days, so stories compare; a faded start means the story began earlier. On a story page it runs from the first article to now.